| Specialty Retail Industry | Consumer Discretionary Sector | Jennifer Lee Pilcher CEO | XSTU Exchange | AU000000CAN2 ISIN |
| AU Country | 98 Employees | - Last Dividend | 19 Jun 2023 Last Split | - IPO Date |
Cann Group Limited is a pioneering company that specializes in the breeding, cultivation, production, manufacturing, supplying, and selling of medicinal cannabis. Founded in the year 2014, it has carved a niche for itself in the medicinal cannabis industry. The company boasts licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. Headquartered in Port Melbourne, Australia, Cann Group Limited stands at the forefront of the medicinal cannabis sector, contributing significantly to research and development in this evolving field.
Cann Group Limited focuses on the breeding and cultivation of cannabis strains specifically tailored for medicinal purposes. Their cultivation practices are designed to produce high-quality cannabis plants that meet the stringent requirements of medicinal cannabis products.
In addition to cultivation, the company is involved in the production and manufacturing of medicinal cannabis. This includes the extraction of active pharmaceutical ingredients (APIs) and the creation of various medicinal cannabis products that adhere to pharmacological standards.
Cann Group Limited is also engaged in the supplying and selling of medicinal cannabis, making their high-quality products available to patients in need. Their comprehensive supply chain ensures that medicinal cannabis reaches patients through legal and regulated channels.
With a license to undertake research, Cann Group Limited is deeply invested in advancing the scientific understanding of cannabis for medicinal use. Their research efforts aim to innovate and enhance the effectiveness, safety, and accessibility of medicinal cannabis treatments.